Eris Lifesciences Limited has informed the Exchange regarding 'update on credit rating of Eris Therapeutics Limited'.
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
India Ratings & Research has reissued its press release on the credit rating of Eris Therapeutics Limited, a group company of Eris Lifesciences. The agency has assigned an 'IND AA' rating with a Stable outlook to Eris Therapeutics' additional bank facilities and affirmed its existing ratings. IND AA is a high investment-grade rating. The update follows an earlier intimation dated 5 May 2025.
Positive for the group. A high AA rating with a Stable outlook on new bank facilities reflects strong financial health and creditworthiness, which can help secure funds at favorable interest rates.